US20170007394A1 - Breast Prostheses, Methods of Manufacturing Breast Prostheses, and Methods of Treatment Using Breast Prostheses - Google Patents
Breast Prostheses, Methods of Manufacturing Breast Prostheses, and Methods of Treatment Using Breast Prostheses Download PDFInfo
- Publication number
- US20170007394A1 US20170007394A1 US15/271,644 US201615271644A US2017007394A1 US 20170007394 A1 US20170007394 A1 US 20170007394A1 US 201615271644 A US201615271644 A US 201615271644A US 2017007394 A1 US2017007394 A1 US 2017007394A1
- Authority
- US
- United States
- Prior art keywords
- breast
- tissue
- graft material
- implant
- tissue expander
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0059—Cosmetic or alloplastic implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C65/00—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor
- B29C65/48—Joining or sealing of preformed parts, e.g. welding of plastics materials; Apparatus therefor using adhesives, i.e. using supplementary joining material; solvent bonding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
- A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2083/00—Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2009/00—Layered products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
Definitions
- Implantable breast prostheses such as breast implants and tissue expanders
- the prostheses can be used for breast augmentation, reconstruction, and/or revision.
- the implants and tissue expanders used in breast surgical procedures are biocompatible and non-reactive, post-surgical complications can result from their use.
- Complications, including capsular contracture, scar formation, implant displacement, rippling, and palpability of implants result in pain and dissatisfaction with breast appearance.
- Research and studies have been conducted to identify surgical techniques and modified implant characteristics that result in reduced incidence of complications.
- graft materials such as acellular dermal tissue matrices such as ALLODERM® or STRATTICETM (LIFECELL CORPORATION, Branchburg, N.J.), along with the implants or tissue expanders.
- tissue matrices can be used to support the breast and to act as a tissue extension or tissue replacement.
- tissue matrices promote regenerative repair rather than scar formation.
- the current standard of care during surgical breast procedures involves separately attaching the graft material to the patient and then placing the prosthesis in the patient.
- the surgeon first separately attaches the graft material to the infra mammary fold (IMF) and the pectoralis major muscle in order to create a submuscular pocket or flap.
- IMF infra mammary fold
- the surgeon places the breast implant or tissue expander inside the pocket.
- the entire process of attaching the graft material to the native tissue takes a lot of time and involves the use of many sutures or other devices to anchor the graft material to the native tissue.
- the current process can also lead to inconsistent results, as inexperienced surgeons may not use graft materials of optimal shape, or may incorrectly position the implant or tissue expander relative to the graft material.
- breast prostheses In accordance with the invention, breast prostheses, methods of making breast prostheses, and methods of treatment using such breast prostheses are provided.
- a prosthesis comprising a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the one or more samples of graft material is attached to the tissue expander by an adhesive that degrades over time.
- a method of making a prosthesis comprises providing a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, and attaching the one or more samples of graft material to the tissue expander by an adhesive that degrades over time.
- a prosthesis comprises a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the tissue expander comprises resorbable tabs or resorbable barbs, and wherein the one or more samples of graft material are attached to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander.
- a method of making a prosthesis comprises providing a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the tissue expander comprises resorbable tabs or resorbable barbs, and attaching the one or more samples of graft material to the tissue expander by the resorbable tabs or resorbable barbs on the tissue expander.
- methods of making a device suitable for use in breast surgical procedures comprise providing one or more samples of graft material and forming a pocket from the graft material that is sized and shaped to hold a tissue expander.
- methods of making a prosthesis comprise providing a tissue expander and one or more samples of graft material, forming a pocket from the graft material that is sized and shaped to hold the breast implant or tissue expander, and inserting the implant into the pocket.
- methods of making a prosthesis comprise preparing a shell of a tissue expander, providing one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, attaching the graft material to the outer shell of the tissue expander prior to curing the shell of the tissue expander, and curing the combined shell of the tissue expander and graft material.
- the method further comprises the step of removing the graft material from the shell.
- FIG. 1A is a perspective view of the components of a prosthesis according to certain exemplary embodiments.
- FIG. 1B is a posterior view of a tissue expander according to certain embodiments.
- FIG. 1C is a side view of a tissue expander according to certain embodiments.
- FIG. 1D is a posterior view of a tissue expander according to certain embodiments.
- FIG. 2 is a perspective view of the components of a prosthesis according to certain exemplary embodiments.
- FIGS. 3A and 3B show a schematic view of a portion of graft material and a portion of a breast implant or tissue expander, illustrating how the two components fit together, according to certain embodiments.
- FIGS. 4A, 4B, and 4C show a schematic view a portion of a breast implant or tissue expander, illustrating exemplary shapes of resorbable tabs, according to certain embodiments.
- FIG. 5 is a schematic view of a tissue expander, as it expands over time, according to certain embodiments.
- FIG. 6 is a view of a sample of graft material with apertures cut in the graft material that correspond to the tabs on the tissue expander of FIG. 5 , according to certain embodiments.
- FIGS. 7A, 7B, 7C, 7D, 7E, and 7F show a schematic view of a portion of graft material and a portion of a tissue expander, illustrating how the tabs on the tissue expander pop out of a smaller hole in the graft material, and fit into the larger hole on the graft material, as the tissue expander expands, according to certain embodiments.
- FIG. 8 is a perspective view of the components of a prosthesis, according to certain embodiments.
- FIG. 9 is a perspective view of a prosthesis, according to certain exemplary embodiments.
- FIGS. 10A and 10B are perspective views of graft material according to certain exemplary embodiments.
- FIGS. 11A and 11B are perspective views of graft materials according to certain exemplary embodiments.
- graft material generally refers to a biocompatible material such as, for example, tissue, processed tissue, or synthetics that can be attached to or inserted into a bodily part.
- breast implant and “implant,” as used herein, generally refer to medical devices that are implanted either under or within breast tissue or under the chest muscle for breast augmentation or reconstruction. Such implants can include saline filled or silicone gel implants, or other implants that provide volume for breast augmentation.
- breast tissue expander or “tissue expander,” as used herein, generally refer to devices that are implanted under or within breast tissue or chest muscle, and which are expanded over time to stretch breast tissue and skin. Unless otherwise indicated, implants and tissue expanders can be used interchangeably with the graft materials, methods or device of attaching graft materials to implants or expanders, methods of forming implants or graft materials, and methods of treatment or use of the devices described herein.
- the term “prosthesis” will be understood to include any implantable device disclosed herein, which comprise an implant and/or tissue expander component.
- the present disclosure relates to prostheses, methods of making prostheses, and methods of treatment using the prostheses.
- the prostheses can be used for breast augmentation, reconstruction, or revision.
- the implantable prostheses and methods discussed herein may be suitable for a wide range of surgical applications.
- the prostheses and methods discussed herein may be suitable for various types of surgical breast procedures, such as, for example, aesthetic surgery associated with mastectomy or lumpectomy, breast reconstruction, breast augmentation, breast enhancement, mastopexy, and revisionary breast surgeries.
- a prosthesis comprising a breast implant or a tissue expander and one or more samples of graft material, wherein the implant or tissue expander is attached to the one or more samples of graft material in a manner that allows the implant or tissue expander and the one or more samples of graft material to be implanted in a patient as one unitary prosthesis; and wherein the implant or tissue expander is attached to the one or more samples of graft material in a manner that will allow the implant or tissue expander and the graft material to be easily separated after a period of time in vivo.
- the prosthesis of the present disclosure comprise tissue expanders.
- the structure of the tissue expander, along with its attachment to a graft material such as an acellular tissue matrix, can allow the tissue expander to be enlarged and removed after a certain period of time, without removing the graft material. Accordingly, the devices and methods of the present disclosure can be beneficial for reconstruction procedures that require removal of tissue expanders.
- the implantable prostheses of the present disclosure can shorten procedure time, reduce the number of surgical sutures and/or staples or other attachment device needed, and reduce the associated costs of surgery.
- the implantable prostheses can also improve surgical outcomes and improve consistency of results by leveling the playing field for inexperienced surgeons.
- the implantable prostheses are believed to reduce the incidence of extrusion and capsular contraction, to block the inflammatory response, and to result in shorter expansion times.
- the implantable prostheses of the present disclosure can be constructed such that the breast implant or tissue expander is easily separated from the graft material after being implanted in vivo.
- the graft material can be removed from tissue expanders which are designed to be removed from the patient after a period of time, and also for breast implants, which are sometimes removed from the patient for revision.
- a prosthesis comprising a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein is the one or more samples of graft material is attached to the breast implant or tissue expander by an adhesive that degrades over time.
- the adhesive can be a synthetic adhesive. Examples of synthetic adhesives include silicone, cyanoacrylates, methyl-ethyl cyanoacrylate, iso(n)butyl-cyanoacrylate (Liquid Bandage Vetbond), octyl-cyanoacrylate (DERMABOND), and Polyethylene glycol(PEG) based associated sealants.
- the adhesive can be a biologically derived glue.
- biologically derived adhesives include marine adhesives, fibrin glue, fibrin sealants (TISSEAL, EVICEL, PROFIBRIX), protein aldehyde sealants (FLOSEAL), mussel adhesive protein, albumin-glutaraldehyde (BIOGLUE).
- a method of making a prosthesis can comprise providing a breast implant or a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, and attaching the one or more samples of graft material to the breast implant or tissue expander with an adhesive that will degrade over time.
- the adhesive can be a synthetic adhesive.
- the adhesive can be a biologically derived glue.
- biologically derived adhesives include marine adhesives, fibrin glue, fibrin sealants (TISSEAL, EVICEL, PROFIBRIX), protein aldehyde sealants (FLOSEAL), mussel adhesive protein, albumin-glutaraldehyde (BIOGLUE).
- FIG. 1A provides a view of the components of one exemplary embodiment of an implantable prosthesis 20 .
- FIG. 1A shows a modeled Style 410 Anatomical Implant (Allergan, Inc. (Santa Barbara, Calif.)) 22 in a vertical orientation and a sample of graft material 21 having a shape produced by modeling graft material covering 50% of implant 22 such that sample of graft material 21 may be bordered by the inframammary fold, the lateral fold, and the inferior edge of the pectoralis major muscle when implanted in a patient.
- FIGS. 1A-1C illustrate prostheses 20 ′ comprising tissue expanders 22 ′ with graft materials 21 .
- the tissue expanders 22 ′ can further include suture tabs 23 for attachment of the expander to tissues.
- the implants or expanders can be formed from a variety of suitable materials.
- the shell of an expander may be produced from a material that is designed to prevent tissue ingrowth and adhesion.
- the tissue expanders 22 ′ are formed of a smooth shell, such as smooth silicon.
- the suture tabs 23 can be formed of a textured materials to allow cellular in-growth, or can be formed of a smooth material (e.g., silicone) that prevents adhesion and allows easy removal of the expander later.
- the adhesive can be applied directly to the portion of the breast implant 22 or tissue expander 22 ′ that will interface with the graft material 21 . In some embodiments the adhesive can be applied directly to the portion of the graft material 21 that will interface with the breast implant 22 or tissue expander 22 ′. In some embodiments the adhesive can be applied directly to both the portion of the breast implant 22 or tissue expander 22 ′ that will interface with the graft material 21 , and to the portion of the graft material 21 that will interface with the breast implant 22 or tissue expander 22 ′.
- the adhesive can be applied in a spray form over to the portion of the breast implant 22 or tissue expander 22 ′ that will interface with the graft material 21 . In some embodiments, the adhesive can be applied in a spray form over the portion of the graft material 21 that will interface with the breast implant 22 or tissue expander 22 ′. In some embodiments, the adhesive can be applied in a spray form over both the portion of the breast implant 22 or tissue expander 22 ′ that will interface with the graft material 21 , and the portion of the graft material 21 that will interface with the breast implant 22 or tissue expander 22 ′.
- the breast implant or tissue expander can be attached to the one or more samples of graft material in a surgical setting or the operating room just prior to the prosthesis being implanted in the patient. In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery. In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery, so that the implantable prosthesis can be sold as a ready-to-use, off the shelf prosthesis.
- a prosthesis comprising a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein the breast implant or tissue expander comprises resorbable tabs or resorbable barbs, and wherein the one or more samples of graft material are attached to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander.
- the resorbable polymers can comprise aliphatic polyester polymers, copolymers, blends thereof, polymers of lactide, galactide, or copolymers thereof, polysaccharides such as cellulose, and oxidized polysaccharides, or other absorbable polymers.
- FIG. 2 shows a breast implant 20 in a vertical orientation and a sample of graft material 21 .
- the implant 20 comprises tabs 23 .
- the graft material 21 comprises corresponding apertures 24 , so that the graft material can be attached to the implant.
- the tabs can be of any geometrical shape that will engage the graft material.
- FIGS. 4A, 4B, and 4C show a schematic view a portion of a breast implant, illustrating that the tabs may be circular 25 , squared 26 , or in the shape of a button 27 .
- FIGS. 1A-1C illustrates tissue expanders 21 ′ tabs 40 , 41 and openings 42 having configurations that may be used with any of the implants or tissue expanders provided herein.
- FIG. 5 depicts an exemplary embodiment of a tissue expander 28 a that comprises tabs 29 a. Over time the tissue expander expands 28 b, and the tabs, being located on the surface of the tissue expander, also move to a positio 29 b.
- FIG. 6 depicts a top view of a sample of graft material 30 with apertures 31 cut to leave room for the tissue expander tabs to pop out of the smaller holes and to engage in the larger holes as the tissue expander and tabs expand, as described, for example, with reference to FIG. 5 .
- FIGS. 7A-7C depict a schematic side view of a portion of a tissue expander 28 a and graft material 30 .
- the tissue expander volume increases 28 b ( FIG. 7B ) and 28 c ( FIG. 7C )
- the location of the tabs increases 29 b and 29 c
- the tissue expander tab 29 a pops out of the smaller hole 31 a , and attaches firmly to the larger hole 31 b .
- the expander 28 can have tabs 29 , 29 ′ of differing sizes, which can accommodate differing sizes of aperatures 31 , which may stretch or enlarge as the tissue expanding enlarges.
- the graft material does not comprise apertures, and the graft material is attached to the resorbable tabs by biodegradable sutures, adhesives that degrade over time, or any means of attachment known by one of skill in the art.
- the implant or tissue expander comprises resorbable barbs.
- FIGS. 8 and 9 depict exemplary embodiments, wherein the implant 20 or tissue expander comprises resorbable barbs 32 , which attach to slits 33 ( FIG. 8 ) or mesh 34 ( FIG. 9 ) on the graft material.
- a method of making an implantable prosthesis can comprise providing a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein the breast implant or tissue expander comprises resorbable tabs or resorbable barbs, and attaching the one or more samples of graft material to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander.
- the breast implant or tissue expander can be attached to the one or more samples of graft material in a surgical setting or the operation room just prior to insertion. In some embodiments the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery. In some embodiments the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery, so that the implantable prosthesis can be sold as a ready-to-use, off the shelf prosthesis.
- methods of making a device suitable for use in breast surgical procedures comprising providing one or more samples of graft material and forming a pocket from the graft material that is sized and shaped to hold a breast implant or tissue expander.
- FIGS. 10A and 10B illustrate the components of one exemplary embodiment.
- the pocket may be formed by cutting a slit through the thickness 35 of the graft material 36 , forming a pocket 37 with an open end 38 .
- FIGS. 11A and 11B illustrate the components of another exemplary embodiment.
- the pocket may be formed by cutting two portions of graft material 36 and attaching the portion with an adhesive, sutures, or any other means known to one of skill in the art to form a pocket 37 with an open end 38 .
- the pocket further comprises suture tabs 39 , for attachment of the pocket to the chest wall.
- methods of making a prosthesis comprising providing a breast implant or tissue expander and one or more samples of graft material, forming a pocket from the graft material that is sized and shaped to hold the breast implant or tissue expander, and inserting the implant into the pocket.
- methods of making a prosthesis comprising preparing the shell of a silicone breast implant or silicone tissue expander, providing one or more samples of graft material sized and shaped to conform to a portion of a surface of a breast implant or tissue expander, attaching the graft material to the shell of the breast implant prior to curing the shell of the silicone breast implant or silicone tissue expander, and curing the shell of the breast implant or tissue expander and the graft material.
- the graft material is an acellular tissue matrix.
- the shell of the breast implant or tissue expander and the acellular tissue matrix are cured such that the curing temperature does not reach a temperature greater than 30° C. In some embodiments the shell of the breast implant or tissue expander and the acellular tissue matrix are cured such that the curing temperature does not exceed 25° C.
- the graft material is an adipose extracellular tissue matrix protein that has been treated to produce a three-dimensional porous, or sponge-like material.
- the shell of the breast implant or tissue expander and the adipose extracellular tissue matrix are cured such that the curing temperature is between 70° C. to 120° C., or between 80° C. to 110° C., or to about 100° C. In some embodiments lower or higher temperatures could be used as long as melting of the matrix proteins does not occur.
- the method of making a prosthesis further comprises the step of removing the graft material from the shell after the curing step but prior to implanting the prosthesis. This step results in a silicone breast implant or tissue expander with the texture of the graft material impressed on the implant.
- the various embodiments of implantable prostheses discussed herein include a sample of graft material.
- the graft materials discussed herein include a sample of biocompatible material.
- the samples of biocompatible material can comprise any suitable synthetic or biologic material, such as, for example, medical grade silicon, autologous or cadaveric tissue, and/or biomatrices, such as, for example, an acellular tissue matrix (“ATM”).
- the sample of biocompatible material may be a flat sheet or sheet-like in form.
- a sample of biocompatible material may be a single layer or may be multi-layered.
- a sample of biocompatible material may be a material that facilitates revascularization and cell repopulation.
- certain embodiments can include an acellular tissue matrix (“ATM”).
- ATM refers to a tissue-derived biomatrix structure that can be made from any of a wide range of collagen-containing tissues by removing all, or substantially all, viable cells and all detectable subcellular components and/or debris generated by killing cells.
- an ATM lacking “substantially all viable cells” is an ATM in which the concentration of viable cells is less than 1% (e.g., less than: 0.1%; 0.01%; 0.001%; 0.0001%; 0.00001%; or 0.000001%) of that in the tissue or organ from which the ATM was made.
- the ATM is treated to produce a three-dimensional porous, or sponge-like material.
- the graft material comprises STRATTICETM, a porcine dermal tissue produced by Lifecell Corporation (Branchburg, N.J.). In some embodiments, the graft material comprises ALLODERM®, an ATM produced from human dermis by the LifeCell Corporation (Branchburg, N.J.).
- the graft material comprises an adipose tissue matrix.
- the graft material is an adipose extracellular tissue matrix protein that has been treated to produce a three-dimensional porous, or sponge-like material.
- the process generally includes obtaining adipose tissue, mechanically processing the adipose tissue to produce small pieces, further processing the tissue to remove substantially all cellular material and/or lipids from the tissue, resuspending the tissue in a solution to form a porous matrix or sponge, and cross-linking the tissue to produce a stable three-dimensional structure.
- ready-to-use, off-the-shelf graft materials that are designed to conform to breast implants of various specifications can be used.
- methods of treatment comprising providing any one of the breast prostheses described above; and implanting the breast prosthesis into a site on a patient where a breast prosthesis is required.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Prostheses (AREA)
- Ceramic Products (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 14/371,291, which was filed on Jul. 9, 2014, which is a 35 U.S.C. §371 national stage filing of International Application Number PCT/US2013/021012, which was filed on Jan. 10, 2013 and claims priority under 35 U.S.C. §119 to U.S. Provisional Application No. 61/586,391, which was filed on Jan. 13, 2012.
- Implantable breast prostheses, such as breast implants and tissue expanders, are used in a wide range of breast surgical procedures. The prostheses can be used for breast augmentation, reconstruction, and/or revision. However, even though the implants and tissue expanders used in breast surgical procedures are biocompatible and non-reactive, post-surgical complications can result from their use. Complications, including capsular contracture, scar formation, implant displacement, rippling, and palpability of implants result in pain and dissatisfaction with breast appearance. Research and studies have been conducted to identify surgical techniques and modified implant characteristics that result in reduced incidence of complications.
- One approach that surgeons use to improve aesthetic outcomes, reduce the risk of complications, and or provide improved revisions is to use graft materials, such as acellular dermal tissue matrices such as ALLODERM® or STRATTICE™ (LIFECELL CORPORATION, Branchburg, N.J.), along with the implants or tissue expanders. These tissue matrices can be used to support the breast and to act as a tissue extension or tissue replacement. In addition, by promoting the organization of the healing process, the tissue matrices promote regenerative repair rather than scar formation.
- The current standard of care during surgical breast procedures involves separately attaching the graft material to the patient and then placing the prosthesis in the patient. For example, in one procedure the surgeon first separately attaches the graft material to the infra mammary fold (IMF) and the pectoralis major muscle in order to create a submuscular pocket or flap. Next, the surgeon places the breast implant or tissue expander inside the pocket. The entire process of attaching the graft material to the native tissue takes a lot of time and involves the use of many sutures or other devices to anchor the graft material to the native tissue. The current process can also lead to inconsistent results, as inexperienced surgeons may not use graft materials of optimal shape, or may incorrectly position the implant or tissue expander relative to the graft material.
- Accordingly, there is a need for an improved breast prostheses, methods of making breast prostheses, and methods of treatment using such breast prostheses.
- In accordance with the invention, breast prostheses, methods of making breast prostheses, and methods of treatment using such breast prostheses are provided.
- According to certain embodiments, a prosthesis is disclosed that comprises a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the one or more samples of graft material is attached to the tissue expander by an adhesive that degrades over time.
- According to certain embodiments, a method of making a prosthesis is disclosed. The method comprises providing a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, and attaching the one or more samples of graft material to the tissue expander by an adhesive that degrades over time.
- According to certain embodiments, a prosthesis is provided. The prosthesis comprises a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the tissue expander comprises resorbable tabs or resorbable barbs, and wherein the one or more samples of graft material are attached to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander.
- According to certain embodiments, a method of making a prosthesis is provided. The method comprises providing a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, wherein the tissue expander comprises resorbable tabs or resorbable barbs, and attaching the one or more samples of graft material to the tissue expander by the resorbable tabs or resorbable barbs on the tissue expander.
- According to certain embodiments, methods of making a device suitable for use in breast surgical procedures are provided. The methods comprise providing one or more samples of graft material and forming a pocket from the graft material that is sized and shaped to hold a tissue expander.
- According to certain embodiments, methods of making a prosthesis are provided. The methods comprise providing a tissue expander and one or more samples of graft material, forming a pocket from the graft material that is sized and shaped to hold the breast implant or tissue expander, and inserting the implant into the pocket.
- According to certain embodiments, methods of making a prosthesis are provided. The method comprise preparing a shell of a tissue expander, providing one or more samples of graft material sized and shaped to conform to a portion of a surface of the tissue expander, attaching the graft material to the outer shell of the tissue expander prior to curing the shell of the tissue expander, and curing the combined shell of the tissue expander and graft material. In certain embodiments, the method further comprises the step of removing the graft material from the shell.
- Furthermore, methods of treatment using the disclosed prostheses are provided.
-
FIG. 1A is a perspective view of the components of a prosthesis according to certain exemplary embodiments. -
FIG. 1B is a posterior view of a tissue expander according to certain embodiments. -
FIG. 1C is a side view of a tissue expander according to certain embodiments. -
FIG. 1D is a posterior view of a tissue expander according to certain embodiments. -
FIG. 2 is a perspective view of the components of a prosthesis according to certain exemplary embodiments. -
FIGS. 3A and 3B show a schematic view of a portion of graft material and a portion of a breast implant or tissue expander, illustrating how the two components fit together, according to certain embodiments. -
FIGS. 4A, 4B, and 4C show a schematic view a portion of a breast implant or tissue expander, illustrating exemplary shapes of resorbable tabs, according to certain embodiments. -
FIG. 5 is a schematic view of a tissue expander, as it expands over time, according to certain embodiments. -
FIG. 6 is a view of a sample of graft material with apertures cut in the graft material that correspond to the tabs on the tissue expander ofFIG. 5 , according to certain embodiments. -
FIGS. 7A, 7B, 7C, 7D, 7E, and 7F show a schematic view of a portion of graft material and a portion of a tissue expander, illustrating how the tabs on the tissue expander pop out of a smaller hole in the graft material, and fit into the larger hole on the graft material, as the tissue expander expands, according to certain embodiments. -
FIG. 8 is a perspective view of the components of a prosthesis, according to certain embodiments. -
FIG. 9 is a perspective view of a prosthesis, according to certain exemplary embodiments. -
FIGS. 10A and 10B are perspective views of graft material according to certain exemplary embodiments. -
FIGS. 11A and 11B are perspective views of graft materials according to certain exemplary embodiments. - Reference will now be made in detail to certain exemplary embodiments of the invention, certain examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
- In this application, the use of the singular includes the plural unless specifically stated otherwise. In this application, the use of “or” means “and/or” unless stated otherwise. Furthermore, the use of the term “including,” as well as other forms, such as “includes” and “included,” is not limiting. Any range described herein will be understood to include the endpoints and all values between the endpoints. Also, terms such as “element” or “component” encompass both elements and components comprising one unit and elements and components that comprise more than one subunit, unless specifically stated otherwise. Also, the use of the term “portion” may include part of a moiety or the entire moiety.
- The section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described. All documents, or portions of documents, cited in this application, including but not limited to patents, patent applications, articles, books, and treatises, are hereby expressly incorporated by reference in their entirety for any purpose.
- The term “graft material,” as used herein, generally refers to a biocompatible material such as, for example, tissue, processed tissue, or synthetics that can be attached to or inserted into a bodily part.
- The terms “breast implant” and “implant,” as used herein, generally refer to medical devices that are implanted either under or within breast tissue or under the chest muscle for breast augmentation or reconstruction. Such implants can include saline filled or silicone gel implants, or other implants that provide volume for breast augmentation. The terms “breast tissue expander” or “tissue expander,” as used herein, generally refer to devices that are implanted under or within breast tissue or chest muscle, and which are expanded over time to stretch breast tissue and skin. Unless otherwise indicated, implants and tissue expanders can be used interchangeably with the graft materials, methods or device of attaching graft materials to implants or expanders, methods of forming implants or graft materials, and methods of treatment or use of the devices described herein. Furthermore, the term “prosthesis” will be understood to include any implantable device disclosed herein, which comprise an implant and/or tissue expander component.
- The present disclosure relates to prostheses, methods of making prostheses, and methods of treatment using the prostheses. The prostheses can be used for breast augmentation, reconstruction, or revision. As such, the implantable prostheses and methods discussed herein may be suitable for a wide range of surgical applications. In various embodiments, the prostheses and methods discussed herein may be suitable for various types of surgical breast procedures, such as, for example, aesthetic surgery associated with mastectomy or lumpectomy, breast reconstruction, breast augmentation, breast enhancement, mastopexy, and revisionary breast surgeries.
- According to certain embodiments, a prosthesis is disclosed that comprises a breast implant or a tissue expander and one or more samples of graft material, wherein the implant or tissue expander is attached to the one or more samples of graft material in a manner that allows the implant or tissue expander and the one or more samples of graft material to be implanted in a patient as one unitary prosthesis; and wherein the implant or tissue expander is attached to the one or more samples of graft material in a manner that will allow the implant or tissue expander and the graft material to be easily separated after a period of time in vivo.
- In certain embodiments, the prosthesis of the present disclosure comprise tissue expanders. Further, the structure of the tissue expander, along with its attachment to a graft material such as an acellular tissue matrix, can allow the tissue expander to be enlarged and removed after a certain period of time, without removing the graft material. Accordingly, the devices and methods of the present disclosure can be beneficial for reconstruction procedures that require removal of tissue expanders.
- By providing the implant or tissue expander and the one or more samples of graft material as one unitary prosthesis, the implantable prostheses of the present disclosure can shorten procedure time, reduce the number of surgical sutures and/or staples or other attachment device needed, and reduce the associated costs of surgery. The implantable prostheses can also improve surgical outcomes and improve consistency of results by leveling the playing field for inexperienced surgeons. The implantable prostheses are believed to reduce the incidence of extrusion and capsular contraction, to block the inflammatory response, and to result in shorter expansion times.
- However, while in some embodiments the breast implants and tissue expanders can be implanted as one unitary prosthesis, the implantable prostheses of the present disclosure can be constructed such that the breast implant or tissue expander is easily separated from the graft material after being implanted in vivo. In various embodiments, the graft material can be removed from tissue expanders which are designed to be removed from the patient after a period of time, and also for breast implants, which are sometimes removed from the patient for revision.
- According to certain embodiments, a prosthesis is disclosed that comprises a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein is the one or more samples of graft material is attached to the breast implant or tissue expander by an adhesive that degrades over time. In some embodiments, the adhesive can be a synthetic adhesive. Examples of synthetic adhesives include silicone, cyanoacrylates, methyl-ethyl cyanoacrylate, iso(n)butyl-cyanoacrylate (Liquid Bandage Vetbond), octyl-cyanoacrylate (DERMABOND), and Polyethylene glycol(PEG) based associated sealants. In some embodiments, the adhesive can be a biologically derived glue. Examples of biologically derived adhesives include marine adhesives, fibrin glue, fibrin sealants (TISSEAL, EVICEL, PROFIBRIX), protein aldehyde sealants (FLOSEAL), mussel adhesive protein, albumin-glutaraldehyde (BIOGLUE).
- According to certain embodiments, a method of making a prosthesis is provided. The method can comprise providing a breast implant or a tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, and attaching the one or more samples of graft material to the breast implant or tissue expander with an adhesive that will degrade over time. In some embodiments, the adhesive can be a synthetic adhesive. Examples of synthetic adhesives include silicone, cyanoacrylates, methyl-ethyl cyanoacrylate, iso(n)butyl-cyanoacrylate (Liquid Bandage Vetbond), octyl-cyanoacrylate (DERMABOND), and Polyethylene glycol(PEG) based associated sealants. In some embodiments, the adhesive can be a biologically derived glue. Examples of biologically derived adhesives include marine adhesives, fibrin glue, fibrin sealants (TISSEAL, EVICEL, PROFIBRIX), protein aldehyde sealants (FLOSEAL), mussel adhesive protein, albumin-glutaraldehyde (BIOGLUE).
-
FIG. 1A provides a view of the components of one exemplary embodiment of animplantable prosthesis 20.FIG. 1A shows a modeled Style 410 Anatomical Implant (Allergan, Inc. (Santa Barbara, Calif.)) 22 in a vertical orientation and a sample ofgraft material 21 having a shape produced by modeling graft material covering 50% ofimplant 22 such that sample ofgraft material 21 may be bordered by the inframammary fold, the lateral fold, and the inferior edge of the pectoralis major muscle when implanted in a patient.FIGS. 1A-1C illustrateprostheses 20′ comprisingtissue expanders 22′ withgraft materials 21. The tissue expanders 22′ can further includesuture tabs 23 for attachment of the expander to tissues. - The implants or expanders can be formed from a variety of suitable materials. For example, the shell of an expander may be produced from a material that is designed to prevent tissue ingrowth and adhesion. For example, in some embodiments, the
tissue expanders 22′ are formed of a smooth shell, such as smooth silicon. Further, thesuture tabs 23 can be formed of a textured materials to allow cellular in-growth, or can be formed of a smooth material (e.g., silicone) that prevents adhesion and allows easy removal of the expander later. - In some embodiments the adhesive can be applied directly to the portion of the
breast implant 22 ortissue expander 22′ that will interface with thegraft material 21. In some embodiments the adhesive can be applied directly to the portion of thegraft material 21 that will interface with thebreast implant 22 ortissue expander 22′. In some embodiments the adhesive can be applied directly to both the portion of thebreast implant 22 ortissue expander 22′ that will interface with thegraft material 21, and to the portion of thegraft material 21 that will interface with thebreast implant 22 ortissue expander 22′. - In some embodiments, the adhesive can be applied in a spray form over to the portion of the
breast implant 22 ortissue expander 22′ that will interface with thegraft material 21. In some embodiments, the adhesive can be applied in a spray form over the portion of thegraft material 21 that will interface with thebreast implant 22 ortissue expander 22′. In some embodiments, the adhesive can be applied in a spray form over both the portion of thebreast implant 22 ortissue expander 22′ that will interface with thegraft material 21, and the portion of thegraft material 21 that will interface with thebreast implant 22 ortissue expander 22′. - In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material in a surgical setting or the operating room just prior to the prosthesis being implanted in the patient. In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery. In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery, so that the implantable prosthesis can be sold as a ready-to-use, off the shelf prosthesis.
- According to certain embodiments, a prosthesis is disclosed that comprises a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein the breast implant or tissue expander comprises resorbable tabs or resorbable barbs, and wherein the one or more samples of graft material are attached to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander. In various embodiments, the resorbable polymers can comprise aliphatic polyester polymers, copolymers, blends thereof, polymers of lactide, galactide, or copolymers thereof, polysaccharides such as cellulose, and oxidized polysaccharides, or other absorbable polymers.
-
FIG. 2 shows abreast implant 20 in a vertical orientation and a sample ofgraft material 21. Theimplant 20 comprisestabs 23. Thegraft material 21 comprises correspondingapertures 24, so that the graft material can be attached to the implant.FIGS. 3A and 3B depict a schematic view of a portion of theimplant 20,resorbable tabs 23,graft material 21, andapertures 24. The tabs can be of any geometrical shape that will engage the graft material.FIGS. 4A, 4B, and 4C show a schematic view a portion of a breast implant, illustrating that the tabs may be circular 25, squared 26, or in the shape of abutton 27. In some embodiments, the tabs are placed in a straight line. In some embodiments, the tabs are placed in a non-linear pattern. Furthermore,FIGS. 1A-1C illustratestissue expanders 21′tabs openings 42 having configurations that may be used with any of the implants or tissue expanders provided herein. -
FIG. 5 depicts an exemplary embodiment of atissue expander 28 a that comprisestabs 29 a. Over time the tissue expander expands 28 b, and the tabs, being located on the surface of the tissue expander, also move to apositio 29 b.FIG. 6 depicts a top view of a sample ofgraft material 30 withapertures 31 cut to leave room for the tissue expander tabs to pop out of the smaller holes and to engage in the larger holes as the tissue expander and tabs expand, as described, for example, with reference toFIG. 5 . -
FIGS. 7A-7C depict a schematic side view of a portion of atissue expander 28 a andgraft material 30. Over time, as the tissue expander volume increases 28 b (FIG. 7B ) and 28 c (FIG. 7C ), the location of the tabs increases 29 b and 29 c, and thetissue expander tab 29 a pops out of thesmaller hole 31 a, and attaches firmly to thelarger hole 31 b. Further, in certain embodiments, as shown inFIGS. 7D-7F , the expander 28 can havetabs aperatures 31, which may stretch or enlarge as the tissue expanding enlarges. - In some exemplary embodiments, the graft material does not comprise apertures, and the graft material is attached to the resorbable tabs by biodegradable sutures, adhesives that degrade over time, or any means of attachment known by one of skill in the art.
- In some embodiments, the implant or tissue expander comprises resorbable barbs.
FIGS. 8 and 9 depict exemplary embodiments, wherein theimplant 20 or tissue expander comprisesresorbable barbs 32, which attach to slits 33 (FIG. 8 ) or mesh 34 (FIG. 9 ) on the graft material. - According to certain embodiments, a method of making an implantable prosthesis is disclosed. The method can comprise providing a breast implant or tissue expander and one or more samples of graft material sized and shaped to conform to a portion of a surface of the breast implant or tissue expander, wherein the breast implant or tissue expander comprises resorbable tabs or resorbable barbs, and attaching the one or more samples of graft material to the breast implant or tissue expander by the resorbable tabs or resorbable barbs on the breast implant or tissue expander.
- In some embodiments, the breast implant or tissue expander can be attached to the one or more samples of graft material in a surgical setting or the operation room just prior to insertion. In some embodiments the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery. In some embodiments the breast implant or tissue expander can be attached to the one or more samples of graft material prior to the surgery, so that the implantable prosthesis can be sold as a ready-to-use, off the shelf prosthesis.
- According to certain embodiments, methods of making a device suitable for use in breast surgical procedures are disclosed comprising providing one or more samples of graft material and forming a pocket from the graft material that is sized and shaped to hold a breast implant or tissue expander.
-
FIGS. 10A and 10B illustrate the components of one exemplary embodiment. According to certain embodiments, the pocket may be formed by cutting a slit through thethickness 35 of thegraft material 36, forming apocket 37 with anopen end 38.FIGS. 11A and 11B illustrate the components of another exemplary embodiment. According to certain embodiments, the pocket may be formed by cutting two portions ofgraft material 36 and attaching the portion with an adhesive, sutures, or any other means known to one of skill in the art to form apocket 37 with anopen end 38. - In some embodiments, the pocket further comprises
suture tabs 39, for attachment of the pocket to the chest wall. - According to certain embodiments, methods of making a prosthesis are disclosed comprising providing a breast implant or tissue expander and one or more samples of graft material, forming a pocket from the graft material that is sized and shaped to hold the breast implant or tissue expander, and inserting the implant into the pocket.
- According to certain embodiments, methods of making a prosthesis are disclosed comprising preparing the shell of a silicone breast implant or silicone tissue expander, providing one or more samples of graft material sized and shaped to conform to a portion of a surface of a breast implant or tissue expander, attaching the graft material to the shell of the breast implant prior to curing the shell of the silicone breast implant or silicone tissue expander, and curing the shell of the breast implant or tissue expander and the graft material.
- In some embodiments the graft material is an acellular tissue matrix. In some embodiments the shell of the breast implant or tissue expander and the acellular tissue matrix are cured such that the curing temperature does not reach a temperature greater than 30° C. In some embodiments the shell of the breast implant or tissue expander and the acellular tissue matrix are cured such that the curing temperature does not exceed 25° C.
- In some embodiments the graft material is an adipose extracellular tissue matrix protein that has been treated to produce a three-dimensional porous, or sponge-like material. In some embodiments the shell of the breast implant or tissue expander and the adipose extracellular tissue matrix are cured such that the curing temperature is between 70° C. to 120° C., or between 80° C. to 110° C., or to about 100° C. In some embodiments lower or higher temperatures could be used as long as melting of the matrix proteins does not occur.
- In certain embodiments the method of making a prosthesis further comprises the step of removing the graft material from the shell after the curing step but prior to implanting the prosthesis. This step results in a silicone breast implant or tissue expander with the texture of the graft material impressed on the implant.
- The various embodiments of implantable prostheses discussed herein include a sample of graft material. The graft materials discussed herein include a sample of biocompatible material. The samples of biocompatible material can comprise any suitable synthetic or biologic material, such as, for example, medical grade silicon, autologous or cadaveric tissue, and/or biomatrices, such as, for example, an acellular tissue matrix (“ATM”). In some embodiments, the sample of biocompatible material may be a flat sheet or sheet-like in form. A sample of biocompatible material may be a single layer or may be multi-layered. In some embodiments, a sample of biocompatible material may be a material that facilitates revascularization and cell repopulation. For example, certain embodiments can include an acellular tissue matrix (“ATM”).
- As used herein, ATM refers to a tissue-derived biomatrix structure that can be made from any of a wide range of collagen-containing tissues by removing all, or substantially all, viable cells and all detectable subcellular components and/or debris generated by killing cells. As used herein, an ATM lacking “substantially all viable cells” is an ATM in which the concentration of viable cells is less than 1% (e.g., less than: 0.1%; 0.01%; 0.001%; 0.0001%; 0.00001%; or 0.000001%) of that in the tissue or organ from which the ATM was made.
- In some embodiments the ATM is treated to produce a three-dimensional porous, or sponge-like material.
- For a description of ATMs that are suitable for use in the present disclosure, as well as methods of making ATMs, see copending U.S. application Ser. No. 12/506,839 (published as US 2011/0022171) at paragraphs 41-73 and U.S. Provisional Application No. 61/491,787 at paragraphs 23-38 and 42-56. The disclosure of both applications is incorporated herein by reference in their entirety. Additionally, as non-limiting examples of methods of producing ATMs, mention is made of the methods described in U.S. Pat. Nos. 4,865,871; 5,366,616; and 6,933,326, and U.S. Patent Application Publication Nos. US2003/0035843 A1, and US 2005/0028228 A1, all of which are incorporated herein by reference in their entirety.
- In some embodiments, the graft material comprises STRATTICE™, a porcine dermal tissue produced by Lifecell Corporation (Branchburg, N.J.). In some embodiments, the graft material comprises ALLODERM®, an ATM produced from human dermis by the LifeCell Corporation (Branchburg, N.J.).
- In some embodiments, the graft material comprises an adipose tissue matrix. In some embodiments the graft material is an adipose extracellular tissue matrix protein that has been treated to produce a three-dimensional porous, or sponge-like material. For a description of adipose tissue matrices that are suitable for use in the present disclosure, as well as methods of making adipose tissue matrices, see copending U.S. Provisional Application No. 61/491,787 at paragraphs 23-38 and 42-56. Briefly, the process generally includes obtaining adipose tissue, mechanically processing the adipose tissue to produce small pieces, further processing the tissue to remove substantially all cellular material and/or lipids from the tissue, resuspending the tissue in a solution to form a porous matrix or sponge, and cross-linking the tissue to produce a stable three-dimensional structure.
- In certain embodiments, ready-to-use, off-the-shelf graft materials that are designed to conform to breast implants of various specifications can be used. For a description of methods of making graft materials that are sized and shaped to conform to a portion of a surface of the breast implant and are suitable for use in the present disclosure, see copending U.S. application Ser. No. 12/506,839 (published as US 2011/0022171). The disclosure of U.S. application Ser. No. 12/506,839 is incorporated herein by reference in its entirety.
- In certain embodiments, methods of treatment are provided comprising providing any one of the breast prostheses described above; and implanting the breast prosthesis into a site on a patient where a breast prosthesis is required.
- Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
Claims (23)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/271,644 US10004590B2 (en) | 2012-01-13 | 2016-09-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US16/000,158 US10695165B2 (en) | 2012-01-13 | 2018-06-05 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US16/881,487 US20200281714A1 (en) | 2012-01-13 | 2020-05-22 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US17/844,950 US20230075361A1 (en) | 2012-01-13 | 2022-06-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261586391P | 2012-01-13 | 2012-01-13 | |
PCT/US2013/021012 WO2013106556A2 (en) | 2012-01-13 | 2013-01-10 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US201414371291A | 2014-07-09 | 2014-07-09 | |
US15/271,644 US10004590B2 (en) | 2012-01-13 | 2016-09-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/371,291 Continuation US9549812B2 (en) | 2012-01-13 | 2013-01-10 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
PCT/US2013/021012 Continuation WO2013106556A2 (en) | 2012-01-13 | 2013-01-10 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/000,158 Continuation US10695165B2 (en) | 2012-01-13 | 2018-06-05 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Publications (2)
Publication Number | Publication Date |
---|---|
US20170007394A1 true US20170007394A1 (en) | 2017-01-12 |
US10004590B2 US10004590B2 (en) | 2018-06-26 |
Family
ID=47633560
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/371,291 Active US9549812B2 (en) | 2012-01-13 | 2013-01-10 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US15/271,644 Active US10004590B2 (en) | 2012-01-13 | 2016-09-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US16/000,158 Active 2033-04-06 US10695165B2 (en) | 2012-01-13 | 2018-06-05 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US16/881,487 Abandoned US20200281714A1 (en) | 2012-01-13 | 2020-05-22 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US17/844,950 Pending US20230075361A1 (en) | 2012-01-13 | 2022-06-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/371,291 Active US9549812B2 (en) | 2012-01-13 | 2013-01-10 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/000,158 Active 2033-04-06 US10695165B2 (en) | 2012-01-13 | 2018-06-05 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US16/881,487 Abandoned US20200281714A1 (en) | 2012-01-13 | 2020-05-22 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US17/844,950 Pending US20230075361A1 (en) | 2012-01-13 | 2022-06-21 | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
Country Status (5)
Country | Link |
---|---|
US (5) | US9549812B2 (en) |
EP (4) | EP3081189B1 (en) |
DK (1) | DK3081189T3 (en) |
ES (3) | ES2596522T3 (en) |
WO (1) | WO2013106556A2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170014226A1 (en) * | 2015-07-15 | 2017-01-19 | Solidago Ag | Self-supporting prosthesis for plastic and reconstructive surgery |
US10307237B2 (en) | 2015-05-15 | 2019-06-04 | Lifecell Corporation | Tissue matrices and methods of treatment |
USD856517S1 (en) | 2016-06-03 | 2019-08-13 | Musculoskeletal Transplant Foundation | Asymmetric tissue graft |
US10695165B2 (en) | 2012-01-13 | 2020-06-30 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
USD895812S1 (en) | 2018-09-07 | 2020-09-08 | Musculoskeletal Transplant Foundation | Soft tissue repair graft |
US10813743B2 (en) | 2018-09-07 | 2020-10-27 | Musculoskeletal Transplant Foundation | Soft tissue repair grafts and processes for preparing and using same |
US10835370B2 (en) | 2009-07-21 | 2020-11-17 | Lifecell Corporation | Graft materials for surgical breast procedures |
US10842612B2 (en) | 2015-08-21 | 2020-11-24 | Lifecell Corporation | Breast treatment device |
US10945831B2 (en) | 2016-06-03 | 2021-03-16 | Musculoskeletal Transplant Foundation | Asymmetric tissue graft |
US10959833B2 (en) | 2012-06-21 | 2021-03-30 | Lifecell Corporation | Implantable prosthesis having acellular tissue attachments |
US11045579B2 (en) | 2016-08-31 | 2021-06-29 | Lifecell Corporation | Breast treatment device |
US11298220B2 (en) | 2019-05-03 | 2022-04-12 | Lifecell Corporation | Breast treatment device |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2915842T3 (en) | 2011-03-09 | 2022-06-27 | Tepha Inc | mastopexy systems |
US9532867B2 (en) | 2013-07-11 | 2017-01-03 | Tepha, Inc. | Absorbable implants for plastic surgery |
WO2015065923A1 (en) * | 2013-10-28 | 2015-05-07 | The Regents Of The University Of California | Tissue grafts with fenestrations |
US9913711B2 (en) * | 2014-06-11 | 2018-03-13 | Robert D. Rehnke | Internal long term absorbable matrix brassiere |
US11883275B2 (en) * | 2014-06-11 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US10595986B2 (en) * | 2014-06-11 | 2020-03-24 | Robert D. Rehnke | Internal long term absorbable matrix brassiere and tissue engineering scaffold |
US11638640B2 (en) | 2014-06-11 | 2023-05-02 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US10799313B2 (en) * | 2015-03-12 | 2020-10-13 | Mentor Worldwide Llc | Tissue expander with pectoral attachment |
USD803401S1 (en) | 2015-04-23 | 2017-11-21 | Tepha, Inc. | Three dimensional mastopexy implant |
USD836778S1 (en) | 2015-10-09 | 2018-12-25 | Tepha, Inc. | Three dimensional mastopexy implant |
EP3413788A2 (en) | 2016-02-09 | 2018-12-19 | Establishment Labs S.A. | Transponders and sensors for implantable medical devices and methods of use thereof |
IL307400A (en) | 2016-10-28 | 2023-12-01 | Estab Labs S A | Tissue expanders, methods of manufacturing and molds tissue expanders, methods of manufacturing and molds thereof |
EP3592397A4 (en) | 2017-03-06 | 2020-12-30 | Tei Biosciences, Inc. | Perforated tissue graft |
USD816221S1 (en) | 2017-04-11 | 2018-04-24 | Tepha, Inc. | Three dimensional mastopexy implant |
USD816220S1 (en) | 2017-04-11 | 2018-04-24 | Tepha, Inc. | Three dimensional mastopexy implant |
WO2018195476A1 (en) | 2017-04-20 | 2018-10-25 | The Regents Of The University Of California | Systems and methods for acellular dermal matrix fenestrations in prepectoral breast reconstruction |
EP3697338A1 (en) * | 2017-10-19 | 2020-08-26 | C.R. Bard, Inc. | Self-gripping hernia prosthesis |
EP3749251B1 (en) | 2018-02-09 | 2023-04-26 | Tepha, Inc. | Full contour breast implant |
USD889654S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
USD889655S1 (en) | 2018-02-09 | 2020-07-07 | Tepha, Inc. | Three dimensional mastopexy implant |
US11844682B2 (en) | 2018-03-12 | 2023-12-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
IT201800003509A1 (en) * | 2018-03-13 | 2019-09-13 | Compagnone Daniele | Mesh or membrane coating based on biological or biosynthetic material for prostheses, with fixing system to the prosthesis itself, and related manufacturing procedure. |
KR20210009302A (en) * | 2018-03-13 | 2021-01-26 | 플라비오 나니 | A mesh or membrane covering made of a biological or biosynthetic material for the prosthesis and comprising a system for fixation on the prosthesis, and a method for manufacturing the corresponding |
USD892329S1 (en) | 2018-07-03 | 2020-08-04 | Tepha, Inc. | Three dimensional mastopexy implant |
EP3860506A4 (en) | 2018-10-02 | 2022-06-29 | Tepha, Inc. | Medical devices to limit movement of breast implants |
US11065075B2 (en) * | 2019-05-20 | 2021-07-20 | Reconstructive Technologies, Llc | Systems and methods for a tissue expander |
JP2023501708A (en) | 2019-11-25 | 2023-01-18 | テファ, インコーポレイテッド | Breast Implant Wraps for Restricting Movement of Breast Implants and Related Methods |
IT202000004183A1 (en) * | 2020-02-28 | 2021-08-28 | Flavio Nanni | Procedure for the realization of a mesh or membrane coating based on biological or biosynthetic material for prostheses, with a fixing system to the prosthesis itself. |
AU2020437689A1 (en) | 2020-03-23 | 2022-10-06 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051648A (en) * | 1995-12-18 | 2000-04-18 | Cohesion Technologies, Inc. | Crosslinked polymer compositions and methods for their use |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US20060206189A1 (en) * | 2004-11-12 | 2006-09-14 | Icon Medical Corp. | Medical adhesive for medical devices |
US20110082481A1 (en) * | 2004-03-30 | 2011-04-07 | Proxy Biomedical Limited | Medical device |
US8383092B2 (en) * | 2007-02-16 | 2013-02-26 | Knc Ner Acquisition Sub, Inc. | Bioadhesive constructs |
US20130224260A1 (en) * | 2008-07-30 | 2013-08-29 | Mesynthes Ltd. | Tissue scaffolds derived from forestomach extracellular matrix |
US20140039617A1 (en) * | 2007-11-14 | 2014-02-06 | G. Patrick Maxwell | Breast Implant Assembly |
US20140141053A1 (en) * | 2012-11-19 | 2014-05-22 | Guill Tool & Engineering Co., Inc. | Microlayer coextrusion to create a time-release drug substance delivery product |
US20140276993A1 (en) * | 2013-03-12 | 2014-09-18 | Soft Tissue Regeneration, Inc. | Absorbable Synthetic Braided Matrix for Breast Reconstruction and Hernia Repair |
US20150150674A1 (en) * | 2012-06-21 | 2015-06-04 | Lifecell Corporation | Implantable prosthesis having acellular tissue attachments |
US20150157451A1 (en) * | 2009-07-21 | 2015-06-11 | Lifecell Corporation | Graft Materials for Surgical Breast Procedures |
US20150313708A1 (en) * | 2012-11-16 | 2015-11-05 | Federico MAYO MARTIN | Breast implant |
US20150374830A1 (en) * | 2011-07-12 | 2015-12-31 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an adhesive sheet containing a drug depot |
US20160324618A1 (en) * | 2014-03-05 | 2016-11-10 | Tela Bio, Inc. | Surgical attachment device |
US9549812B2 (en) * | 2012-01-13 | 2017-01-24 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US20170056157A1 (en) * | 2011-12-20 | 2017-03-02 | Lifecell Corporation | Sheet tissue products |
US20170065822A1 (en) * | 2012-07-26 | 2017-03-09 | Nyxoah SA | Electrical contacts on a medical device patch |
US20170100509A1 (en) * | 2010-07-08 | 2017-04-13 | Lifecell Corporation | Method for shaping tissue matrices |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2108205A (en) | 1936-12-01 | 1938-02-15 | Elsie L Martin | Breast pad and the like |
US3683424A (en) | 1970-01-30 | 1972-08-15 | William J Pangman | Surgically implantable compound breast prosthesis |
US4298998A (en) | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4984585A (en) | 1983-02-17 | 1991-01-15 | Austad Eric D | Tissue expander |
US4865871A (en) | 1983-08-23 | 1989-09-12 | Board Of Regents The University Of Texas System | Method for cryopreparing biological tissue |
AU593267B2 (en) | 1986-07-22 | 1990-02-08 | Paul O'keeffe | Implantable fabric pouch for mammary prothesis |
BR8705600A (en) | 1987-10-15 | 1988-08-02 | Ricardo Alfredo Bustos | BREAST PROSTHESIS |
US5366616A (en) | 1987-12-15 | 1994-11-22 | Uop | Hydrocarbon conversion process using a chromium substituted molecular sieve |
US5282856A (en) * | 1987-12-22 | 1994-02-01 | Ledergerber Walter J | Implantable prosthetic device |
GB8809294D0 (en) | 1988-04-20 | 1988-05-25 | Werner Audretsch | Tissue expanders |
FR2630637B1 (en) * | 1988-04-27 | 1997-09-12 | Muller Guy Henri | NEW ALVEOLAR PROSTHESIS |
US5066303A (en) * | 1989-08-07 | 1991-11-19 | Medical Engineering Corporation | Self-sealing tissue expander and method |
US8067149B2 (en) | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
US5356429A (en) | 1991-05-16 | 1994-10-18 | Seare William J Jr | Body pocket maintenance prosthesis |
FR2682284A1 (en) | 1991-10-14 | 1993-04-16 | Dessapt Bernard | Mammary prosthesis |
EP0542242B1 (en) * | 1991-11-14 | 1997-06-04 | AMOENA Medizin-Orthopädie-Technik GmbH | Process for manufacturing a mammary prosthesis |
US5391203A (en) | 1992-04-13 | 1995-02-21 | Scott P. Bartlett | Method of draining and filling soft tissue implant |
FR2709947B1 (en) | 1993-09-13 | 1995-11-10 | Bard Sa Laboratoires | Curved prosthetic mesh and its manufacturing process. |
US5437824A (en) | 1993-12-23 | 1995-08-01 | Moghan Medical Corp. | Method of forming a molded silicone foam implant having open-celled interstices |
EP0744968A1 (en) * | 1994-02-17 | 1996-12-04 | W.L. Gore & Associates, Inc. | A carvable ptfe implant material |
US5658328A (en) | 1995-03-30 | 1997-08-19 | Johnson; Gerald W. | Endoscopic assisted mastopexy |
US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5676161A (en) | 1995-04-24 | 1997-10-14 | Baylor College Of Medicine | Surgical procedures for mastopexy and reduction mammaplasty |
US5584884A (en) | 1995-07-27 | 1996-12-17 | Anthony S. Pignataro | Mammary prosthesis and method of surgically implanting same |
FR2746298A1 (en) | 1996-03-25 | 1997-09-26 | Bellity Philippe | Surgical support prosthesis for human breast |
US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
ES2208974T3 (en) | 1996-08-23 | 2004-06-16 | Cook Biotech, Inc. | PROTESIS OF GRAFT, MATERIALS AND METHODS. |
US6666892B2 (en) | 1996-08-23 | 2003-12-23 | Cook Biotech Incorporated | Multi-formed collagenous biomaterial medical device |
JPH10158906A (en) | 1996-11-22 | 1998-06-16 | Torinpu Internatl Japan Kk | Clothes for female |
FR2762207B1 (en) | 1997-04-17 | 1999-07-30 | Ethnor | IMPROVEMENTS ON SUBCUTANEOUS PROSTHESES FOR BREAST PLASTY |
US6638308B2 (en) | 1997-10-10 | 2003-10-28 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
US7658727B1 (en) * | 1998-04-20 | 2010-02-09 | Medtronic, Inc | Implantable medical device with enhanced biocompatibility and biostability |
ES2323661T3 (en) | 1998-06-05 | 2009-07-22 | Organogenesis Inc. | METHOD OF PREPARATION OF A VASCULAR PROTESIS. |
US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
US6099566A (en) | 1998-09-04 | 2000-08-08 | Pmt Corporation | Prosthetic implant valve cover |
US6723133B1 (en) | 1998-09-11 | 2004-04-20 | C. R. Bard, Inc. | Performed curved prosthesis having a reduced incidence of developing wrinkles or folds |
US6740122B1 (en) | 1998-09-11 | 2004-05-25 | C. R. Bard, Inc. | Preformed curved prosthesis that is adapted to the external iliac vessels |
PT1612265E (en) | 1998-11-19 | 2013-03-14 | Organogenesis Inc | Bioengineered tissue constructs and methods for producing and using them |
US20030082152A1 (en) | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
US6203570B1 (en) | 1999-11-24 | 2001-03-20 | John L. Baeke | Breast implant with position lock |
CA2422852C (en) | 2000-09-18 | 2012-06-26 | Organogenesis Inc. | Methods for treating a patient using a bioengineered flat sheet graft prostheses |
US6913626B2 (en) * | 2001-08-14 | 2005-07-05 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US8049059B2 (en) | 2001-10-26 | 2011-11-01 | Cook Biotech Incorporated | Medical graft device with meshed structure |
US20110009960A1 (en) | 2001-11-16 | 2011-01-13 | Allergan, Inc. | Prosthetic fabric structure |
US7651684B2 (en) * | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
EP1494597A4 (en) * | 2002-04-01 | 2006-05-03 | Univ Texas | Composite material for wound repair |
US7011688B2 (en) | 2002-05-10 | 2006-03-14 | C.R. Bard, Inc. | Prosthetic repair fabric |
US6736823B2 (en) | 2002-05-10 | 2004-05-18 | C.R. Bard, Inc. | Prosthetic repair fabric |
US6736854B2 (en) | 2002-05-10 | 2004-05-18 | C. R. Bard, Inc. | Prosthetic repair fabric with erosion resistant edge |
IL150151A (en) | 2002-06-11 | 2010-11-30 | Mim Minimally Invasive Mastopexy Ltd | System for breast lifting |
AU2003295322B2 (en) | 2002-08-21 | 2009-06-18 | Revivicor, Inc. | Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
WO2004096098A1 (en) | 2003-04-29 | 2004-11-11 | Formhold Medical Investment Holdings | Prothesis for soft tissue support |
US7081135B2 (en) | 2003-06-09 | 2006-07-25 | Lane Fielding Smith | Mastopexy stabilization apparatus and method |
US20040260315A1 (en) | 2003-06-17 | 2004-12-23 | Dell Jeffrey R. | Expandable tissue support member and method of forming the support member |
US20050028228A1 (en) | 2003-07-21 | 2005-02-03 | Lifecell Corporation | Acellular tissue matrices made from alpa-1,3-galactose-deficient tissue |
US6802861B1 (en) | 2003-08-26 | 2004-10-12 | Rsh-Gs Trust | Structured breast implant |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
ITMI20032448A1 (en) | 2003-12-12 | 2005-06-13 | Angiologica B M S R L | REINFORCEMENT PARIETAL PROSTHESIS AND METHOD OF REALIZING THE SAME. |
CN1953657A (en) | 2004-03-17 | 2007-04-25 | 雷维维科公司 | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
DK1734814T3 (en) | 2004-03-17 | 2015-04-07 | Revivicor Inc | Tissue DERIVED FROM ANIMALS IS MISSING ANY EXPRESSION OF FUNCTIONAL ALPHA-1,3 galactosyltransferase |
US7351197B2 (en) | 2004-05-07 | 2008-04-01 | Ams Research Corporation | Method and apparatus for cystocele repair |
US7476249B2 (en) | 2004-08-06 | 2009-01-13 | Frank Robert E | Implantable prosthesis for positioning and supporting a breast implant |
US8007531B2 (en) | 2004-08-06 | 2011-08-30 | Frank Robert E | Implantable prosthesis for positioning and supporting a breast implant |
EP1796693A2 (en) * | 2004-08-26 | 2007-06-20 | Chandrashekhar P. Pathak | Implantable tissue compositions and method |
US7641688B2 (en) | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US20100303880A1 (en) | 2005-04-28 | 2010-12-02 | Reddy Harry K | Tissue scaffolding comprising surface folds for tissue engineering |
WO2006135998A2 (en) | 2005-06-24 | 2006-12-28 | Wagenfuhr Jr J | Implantable prosthesis with double convexity |
WO2007000756A2 (en) | 2005-06-28 | 2007-01-04 | Ami Glicksman | Human implantable tissue expander |
WO2007004214A2 (en) | 2005-07-04 | 2007-01-11 | Sergey Popov | Implant assembly |
EP1937183B1 (en) | 2005-09-12 | 2018-11-28 | Proxy Biomedical Limited | Soft tissue implants |
US20070065483A1 (en) * | 2005-09-21 | 2007-03-22 | Chudzik Stephen J | In vivo formed matrices including natural biodegradable polysaccharides and uses thereof |
US20070088299A1 (en) | 2005-10-17 | 2007-04-19 | Emily Ayre | Emesis kit |
US20070116678A1 (en) | 2005-11-23 | 2007-05-24 | Hsing-Wen Sung | Medical device with living cell sheet |
US20080260853A1 (en) | 2006-02-22 | 2008-10-23 | Firestone Leigh H | Extracellular matrix as surgical adjunct in a lumpectomy procedure |
DE102006029605A1 (en) | 2006-06-26 | 2007-12-27 | Lazar, Harald, Dr. | Breast implant for cosmetic purpose, has network with two fixing units that are formed by holding threads that are connected at cross points in material connection manner, where surface of network is provided with hydrophilic coating |
US8480557B2 (en) | 2006-07-27 | 2013-07-09 | Refine, Llc | Nonaugmentive mastopexy |
ES2375875T3 (en) | 2006-07-31 | 2012-03-07 | Organogenesis, Inc. | MASTOPEXY AND MATERIAL RECONSTRUCTION PROSTHESIS. |
EP2076214A2 (en) | 2006-10-03 | 2009-07-08 | Alure Medical, Inc. | Minimally invasive tissue support |
US8795384B2 (en) | 2007-01-10 | 2014-08-05 | Cook Biotech Incorporated | Implantable devices useful for reinforcing a surgically created stoma |
CA2682190C (en) | 2007-03-29 | 2015-01-27 | Tyrx Pharma, Inc. | Biodegradable, polymer coverings for breast implants |
US20080281418A1 (en) | 2007-05-09 | 2008-11-13 | Leigh Hunt Firestone | Breast implant articles of multi-layered sheets of extracellular matrix or balled strips and pieces of extracellular matrix |
US20080281419A1 (en) | 2007-05-10 | 2008-11-13 | Matheny Robert G | Breast implants and compositions of extracellular matrix |
US9149496B2 (en) * | 2007-05-10 | 2015-10-06 | Cormatrix Cardiovascular, Inc. | ECM Constructs for treating damaged biological tissue |
CL2008001272A1 (en) | 2007-06-24 | 2008-10-03 | Gary Pierre Lauryssen | PROSTHETIC HOLDING OF HUMAN MOMS THAT INCLUDES A CONTINUOUS BIOCOMPATIBLE MESH SHEET WITH A CUP FORM THAT CAN BE INSURED BETWEEN THE SKIN AND GLANDULAR STRUCTURE OF A HUMAN BREAD WITH AN OPENING THROUGH WHICH THE STRUCTURE IS LOCATED |
EP2190382B1 (en) | 2007-09-19 | 2018-10-24 | Ethicon, Inc | Naturally contoured, preformed, three dimensional mesh device for breast implant support |
US8101116B2 (en) | 2007-09-19 | 2012-01-24 | Ethicon, Inc. | Preformed support device and method and apparatus for manufacturing the same |
BRPI0816524A2 (en) | 2007-10-16 | 2015-03-24 | Orbix Medical Ltda | "Soft tissue molding system, method for molding a patient's soft tissue and laminate material" |
US8313527B2 (en) * | 2007-11-05 | 2012-11-20 | Allergan, Inc. | Soft prosthesis shell texturing method |
US20110035004A1 (en) | 2007-11-14 | 2011-02-10 | Maxwell G | Interfaced medical implant |
US8425600B2 (en) * | 2007-11-14 | 2013-04-23 | G. Patrick Maxwell | Interfaced medical implant assembly |
US20110293666A1 (en) | 2007-11-28 | 2011-12-01 | Xianyan Wang | Bioengineered Tissue Constructs and Methods for Production and Use |
US20090198332A1 (en) | 2008-02-05 | 2009-08-06 | Hilton Becker | Method for texturing the surface of a synthetic implant |
EP2254607B1 (en) * | 2008-03-14 | 2015-04-01 | Cook Biotech Incorporated | Graft materials and methods for staged delivery of bioactive components |
US20100023029A1 (en) | 2008-07-23 | 2010-01-28 | Bodyaesthetic Research Center, Inc. | Mesh Device for Immediate Breast Construction and Uses Thereof |
JP2013517292A (en) | 2010-01-14 | 2013-05-16 | オーガノジェネシス・インコーポレイテッド | Bioengineered tissue constructs and methods for generating and using the same |
EP2528538A2 (en) * | 2010-01-28 | 2012-12-05 | Allergan, Inc. | Open celled silicone foams, implants including them and processes for making same |
EP2531226A1 (en) * | 2010-02-05 | 2012-12-12 | Allergan, Inc. | Biocompatible structures and compositions |
US20140257481A1 (en) | 2010-04-29 | 2014-09-11 | BioStruxs, LLC | Breast Reconstruction Device and Methods |
US8858647B2 (en) | 2010-05-05 | 2014-10-14 | Barry Markman | Method and apparatus for a process creating an internal tissue graft for animal and human reconstructive purposes |
ES2623475T3 (en) * | 2010-05-11 | 2017-07-11 | Allergan, Inc. | Porogen compositions, methods for making them and uses |
ES2915842T3 (en) | 2011-03-09 | 2022-06-27 | Tepha Inc | mastopexy systems |
US20140088700A1 (en) * | 2011-06-08 | 2014-03-27 | Allergan, Inc. | Method for using a silk derived bioresorbable scaffold in breast reconstruction |
US20150119353A1 (en) | 2012-02-22 | 2015-04-30 | Kci Licensing, Inc. | Antimicrobial compositions, the preparation and use thereof |
WO2013134269A2 (en) | 2012-03-06 | 2013-09-12 | Kci Licensing, Inc. | New compositions, the preparation and use thereof |
WO2014123665A1 (en) | 2013-02-06 | 2014-08-14 | Kci Licensing, Inc. | Polymers, preparation and use thereof |
US9655715B2 (en) * | 2013-07-11 | 2017-05-23 | Tepha, Inc. | Absorbable implants for plastic surgery |
WO2015065923A1 (en) * | 2013-10-28 | 2015-05-07 | The Regents Of The University Of California | Tissue grafts with fenestrations |
US10595986B2 (en) * | 2014-06-11 | 2020-03-24 | Robert D. Rehnke | Internal long term absorbable matrix brassiere and tissue engineering scaffold |
WO2016077480A1 (en) * | 2014-11-11 | 2016-05-19 | Duke University | Compositions and methods for the prevention and/or reduction of scarring |
RU2749991C2 (en) | 2016-08-31 | 2021-06-21 | Лайфселл Корпорейшн | Device for mammary gland correction |
-
2013
- 2013-01-10 ES ES13702528.4T patent/ES2596522T3/en active Active
- 2013-01-10 DK DK16171805.1T patent/DK3081189T3/en active
- 2013-01-10 US US14/371,291 patent/US9549812B2/en active Active
- 2013-01-10 EP EP16171805.1A patent/EP3081189B1/en not_active Not-in-force
- 2013-01-10 WO PCT/US2013/021012 patent/WO2013106556A2/en active Application Filing
- 2013-01-10 ES ES16171805.1T patent/ES2689698T3/en active Active
- 2013-01-10 EP EP20167202.9A patent/EP3708117A1/en not_active Withdrawn
- 2013-01-10 EP EP13702528.4A patent/EP2802288B1/en not_active Not-in-force
- 2013-01-10 EP EP18173830.3A patent/EP3400900B1/en active Active
- 2013-01-10 ES ES18173830T patent/ES2812281T3/en active Active
-
2016
- 2016-09-21 US US15/271,644 patent/US10004590B2/en active Active
-
2018
- 2018-06-05 US US16/000,158 patent/US10695165B2/en active Active
-
2020
- 2020-05-22 US US16/881,487 patent/US20200281714A1/en not_active Abandoned
-
2022
- 2022-06-21 US US17/844,950 patent/US20230075361A1/en active Pending
Patent Citations (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051648A (en) * | 1995-12-18 | 2000-04-18 | Cohesion Technologies, Inc. | Crosslinked polymer compositions and methods for their use |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US20110082481A1 (en) * | 2004-03-30 | 2011-04-07 | Proxy Biomedical Limited | Medical device |
US20060206189A1 (en) * | 2004-11-12 | 2006-09-14 | Icon Medical Corp. | Medical adhesive for medical devices |
US8383092B2 (en) * | 2007-02-16 | 2013-02-26 | Knc Ner Acquisition Sub, Inc. | Bioadhesive constructs |
US20140039617A1 (en) * | 2007-11-14 | 2014-02-06 | G. Patrick Maxwell | Breast Implant Assembly |
US20130224260A1 (en) * | 2008-07-30 | 2013-08-29 | Mesynthes Ltd. | Tissue scaffolds derived from forestomach extracellular matrix |
US20140257482A1 (en) * | 2008-07-30 | 2014-09-11 | Mesynthes Ltd. | Tissue scaffolds derived from forestomach extracellular matrix |
US20150157451A1 (en) * | 2009-07-21 | 2015-06-11 | Lifecell Corporation | Graft Materials for Surgical Breast Procedures |
US20170100509A1 (en) * | 2010-07-08 | 2017-04-13 | Lifecell Corporation | Method for shaping tissue matrices |
US20150374830A1 (en) * | 2011-07-12 | 2015-12-31 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an adhesive sheet containing a drug depot |
US20170056157A1 (en) * | 2011-12-20 | 2017-03-02 | Lifecell Corporation | Sheet tissue products |
US9549812B2 (en) * | 2012-01-13 | 2017-01-24 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US20150150674A1 (en) * | 2012-06-21 | 2015-06-04 | Lifecell Corporation | Implantable prosthesis having acellular tissue attachments |
US20170065822A1 (en) * | 2012-07-26 | 2017-03-09 | Nyxoah SA | Electrical contacts on a medical device patch |
US20150313708A1 (en) * | 2012-11-16 | 2015-11-05 | Federico MAYO MARTIN | Breast implant |
US20140141053A1 (en) * | 2012-11-19 | 2014-05-22 | Guill Tool & Engineering Co., Inc. | Microlayer coextrusion to create a time-release drug substance delivery product |
US20140276993A1 (en) * | 2013-03-12 | 2014-09-18 | Soft Tissue Regeneration, Inc. | Absorbable Synthetic Braided Matrix for Breast Reconstruction and Hernia Repair |
US20160324618A1 (en) * | 2014-03-05 | 2016-11-10 | Tela Bio, Inc. | Surgical attachment device |
US20170027678A1 (en) * | 2014-03-05 | 2017-02-02 | Tela Bio, Inc. | Surgical attachment device |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10835370B2 (en) | 2009-07-21 | 2020-11-17 | Lifecell Corporation | Graft materials for surgical breast procedures |
US11179235B2 (en) | 2009-07-21 | 2021-11-23 | Lifecell Corporation | Graft materials for surgical breast procedures |
US10695165B2 (en) | 2012-01-13 | 2020-06-30 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US10959833B2 (en) | 2012-06-21 | 2021-03-30 | Lifecell Corporation | Implantable prosthesis having acellular tissue attachments |
US10307237B2 (en) | 2015-05-15 | 2019-06-04 | Lifecell Corporation | Tissue matrices and methods of treatment |
US20170014226A1 (en) * | 2015-07-15 | 2017-01-19 | Solidago Ag | Self-supporting prosthesis for plastic and reconstructive surgery |
US10842612B2 (en) | 2015-08-21 | 2020-11-24 | Lifecell Corporation | Breast treatment device |
USD856517S1 (en) | 2016-06-03 | 2019-08-13 | Musculoskeletal Transplant Foundation | Asymmetric tissue graft |
US10945831B2 (en) | 2016-06-03 | 2021-03-16 | Musculoskeletal Transplant Foundation | Asymmetric tissue graft |
US11045579B2 (en) | 2016-08-31 | 2021-06-29 | Lifecell Corporation | Breast treatment device |
USD895812S1 (en) | 2018-09-07 | 2020-09-08 | Musculoskeletal Transplant Foundation | Soft tissue repair graft |
US10813743B2 (en) | 2018-09-07 | 2020-10-27 | Musculoskeletal Transplant Foundation | Soft tissue repair grafts and processes for preparing and using same |
US11642216B2 (en) | 2018-09-07 | 2023-05-09 | Musculoskeletal Transplant Foundation | Soft tissue repair grafts and processes for preparing and using same |
US11298220B2 (en) | 2019-05-03 | 2022-04-12 | Lifecell Corporation | Breast treatment device |
Also Published As
Publication number | Publication date |
---|---|
US20180280132A1 (en) | 2018-10-04 |
EP3400900B1 (en) | 2020-05-20 |
US20200281714A1 (en) | 2020-09-10 |
WO2013106556A2 (en) | 2013-07-18 |
US10004590B2 (en) | 2018-06-26 |
US9549812B2 (en) | 2017-01-24 |
US20230075361A1 (en) | 2023-03-09 |
EP2802288A2 (en) | 2014-11-19 |
ES2596522T3 (en) | 2017-01-10 |
US10695165B2 (en) | 2020-06-30 |
EP3081189A1 (en) | 2016-10-19 |
DK3081189T3 (en) | 2018-10-22 |
EP3400900A1 (en) | 2018-11-14 |
EP3708117A1 (en) | 2020-09-16 |
EP2802288B1 (en) | 2016-07-27 |
ES2689698T3 (en) | 2018-11-15 |
WO2013106556A3 (en) | 2013-09-12 |
ES2812281T3 (en) | 2021-03-16 |
US20150012089A1 (en) | 2015-01-08 |
EP3081189B1 (en) | 2018-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230075361A1 (en) | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses | |
AU2019204011B2 (en) | Implantable prosthesis having acellular tissue attachments | |
CA2705349C (en) | Breast implant assembly to reduce capsular contracture | |
US20150250582A1 (en) | Breast reconstruction device | |
US20230107339A1 (en) | Meshed dermal tissue matrix products | |
US20200315776A1 (en) | Composite tissue product anchor bolster for three-dimensional biologic scaffolds and related methods | |
Stanizzi et al. | Use of Acellular Dermal Matrix (ADM) for the Correction of Breast Implant Malposition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT, MINNESOTA Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237 Effective date: 20161006 Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE Free format text: LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNORS:KCI USA, INC.;LIFECELL CORPORATION;KCI LICENSING, INC.;REEL/FRAME:040291/0237 Effective date: 20161006 |
|
AS | Assignment |
Owner name: LIFECELL CORPORATION, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHETTY, DHANURAJ;BARERE, AARON;FRIEDMAN, EVAN;AND OTHERS;SIGNING DATES FROM 20141106 TO 20150217;REEL/FRAME:039976/0082 |
|
AS | Assignment |
Owner name: LIFECELL CORPORATION, NEW JERSEY Free format text: RELEASE OF SECURITY INTEREST 037845/0497;ASSIGNOR:WILMINGTON TRUST;REEL/FRAME:041608/0603 Effective date: 20170131 Owner name: LIFECELL CORPORATION, NEW JERSEY Free format text: RELEASE OF SECURITY INTEREST 040098/0268;ASSIGNOR:WILMINGTON TRUST;REEL/FRAME:041608/0554 Effective date: 20170131 Owner name: LIFECELL CORPORATION, NEW JERSEY Free format text: RELEASE OF SECURITY INTEREST 040291/0237;ASSIGNOR:WILMINGTON TRUST;REEL/FRAME:041608/0702 Effective date: 20170131 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |